chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Date of Admission: 11/10/2021   Date of Death:11/21/2021   Reason for Hospital Admission (Admitting Diagnosis): Covid pneumonia, acute hypoxic respiratory failure 89 Y male with purported dementia (per family, not clear if formally diagnosed), hypertension, hyperlipidemia, glaucoma, had recent covid booster on 11/5 who presented to ED on 11/10 with fatigue, shortness of breath, cough, anorexia.  Found to have covid pneumonia with acute hypoxic respiratory failure.  CXR with multifocal pneumonia.     Covid pneumonia/acute hypoxic respiratory failure:  Symptom onset 11/5, covid positive 11/10.  Pt received 5 day course of redemsivir (11/11-11/15/21), dose of tocilizumab (11/13/21), and high dose steroids.  Otherwise CTA of chest on 11/13 was negative for PE.  Despite the aforementioned treatments, pt continued to deteriorate with escalating oxygen requirements up to 60L and 100% high flow oxygen.  Family decided to forego ICU care and mechanical intubation.  After further discussions with family (grandson served as family spokesperson), they made difficult decision for comfort care on 11/19/21.  High flow oxygen removed, placed on morphine drip, and limited family members were allowed to visit.  Patient subsequently expired at 14:46 on 11/21/21.
Fever, chills, headache, dizziness, nausea, body ache. It lasted from Saturday around 2 am to well around Monday morning. It was worse and longer that the first dose
Fever began at night, and increased in intensity and duration over the next week. After several visits to both Urgent Care and her primary Physician, it was assumed that she had a viral infection.  On 10/28, she was seen again by her primary and they noted ulcers in her mouth and suggested HFMD.  On 11/1/2010 she was again seen by Dr., as her fevers were getting worse (105.3). She had no other symptoms of being ill, but a CBC was done and a diagnosis of febrile neutropenia was made.
CHILD SAID HER NECK HURT. AFTER MOTRIN SHE FELT BETTER BUT ABOUT AN HOUR LATER SAID THAT SHE HAD A HEADACHE AND HAD A FEVER. THE FEVER REACHED ABOUT 103.5  Fahrenheit
No additional adverse event or product quality concern; She reports that a vial of PNEUMOVAX 23 (0.5ml) was drawn up in a syringe along with 0.7ml of STERILE DILUENT and administered.; This spontaneous report has been received from a medical assistant, referring to an unknown age and gender patient. The patient's pertinent medical history, concurrent conditions, drug reaction or allergies, and concomitant medication were not reported.  On 30-JUN-2021 the vaccine Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23) vial 0.5 milliliter (lot number T028446 has been verified to be a valid lot number for Pneumococcal Vaccine, Polyvalent (23-valent), with expiration date 15-JUL-2022) (vaccination scheme, route of administration and anatomical location were not reported) was drawn up in a syringe along with sterile diluent 0.7 milliliter (lot number and expiration date unknown as it was discarded) and were administered as prophylaxis (product preparation issue). No adverse events were reported.
Initial report received from the health care professional on 10 Aug 2010: The health care professional suspects that this patient might have received only a partial dose of MENVEO because the patient received only the MenA lyophilized component of MENVEO (batch number: 100005), dose: unknown) intramuscularly on an unspecified date.
Pt recvd vax 28DEC93 415PM & pt was described as sleepy & whiney during the evening w/fever; tx'd w/APAP; pt became limp & lifeless; taken to ER via ambulance when lifeless activity dxd as convul secondary to vax;
Multiple (~ 20) papules/pustules on body/back ~ 22 days after vaccine. No fever.
Really bad pain in the lymph node area of the armpit and breast area 2 days after the first shot; Really bad pain in the lymph node area of the armpit and breast area 2 days after the first shot; This is a spontaneous report from a contactable consumer (patient reported for herself).  A 33-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection, Batch/Lot Number: EW0177, expiration date unknown) 1st dose, via an unspecified route of administration administered in Arm Left on 18May2021 17:00 (33-year-old at the time of vaccination) as 1st dose, single for covid-19 immunization. Medical history included ongoing thyroid disorder discovered about 2 years ago from 2019 when she had blood work done and birth control (from at least 10 years). Concomitant medication(s) included levothyroxine 0.1 mg, once daily (100mcg 1 tablet by mouth) taken for thyroid disorder from an unspecified start date (has been on it for about 2 years now) and ethinylestradiol, norgestimate (TRI FEMYNOR) once daily taken for birth control from an unspecified start date (has been on it for at least 10 years) and both were ongoing. On 20May2021, 2 days after the first shot, she had really bad pain in the lymph node area of the armpit and breast area. It was reported that on 18May2021 the patient received first dose of vaccine and two days after that shot on 20May2021 she experienced really bad pain in the lymph node area of the armpit and breast area. She wanted to know if that was side effect. She said she could have sworn that she read that a vaccine could travel to the lymph node. The reporter stated that the pain started 20May2021. It was 2 or 3 days for the soreness to go down. It lasted 3 days. The reporter further confirmed that it was completely resolved. patient had not received any treatment. She also stated that she was getting vaccine because travelling and they have a lot of restrictions and she said she wanted to have kids and that was her main concern. The outcome of the events were resolved on 23May2021.   Information on Lot/Batch number was available. Additional information has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021728456 Same reporter/ drug, different patient/ AE
plaintiffs allege that as a result of 2 vax w/DTP 15JUL & 24AUG92, pt devel seizures shortly p/the 2nd vax & currently displays sx, delayed devel & mental retardation; they state neuromuscular dystrophy was noted 1JUN83 prior to vax;
Triggered asthma attack that lasted 5 hours-Use of rescue inhaler (Allupent) and 2mg albuterol tab.
Information has been received from a nurse concerning a 15 year old female with a history of scarring from a motor vehicle accident and no known drug allergies who on 06-OCT-2007 was vaccinated IM in the left arm with the first dose of GARDASIL.  There was no concomitant medication.  On 06-OCT-2007 the patient experienced injection site reaction described as covering a 2 to 3 inch area around the injection site that was blanched with small pea sized elevations.  The reaction occurred several hours after the injection and lasted for about 2 months.  The rash subsided without any treatment.  The patient reported the reaction about six months after receiving the vaccination.  No other symptoms reported.  Unknown medical attention was sought in the office.  No product quality complaint was involved.  Additional information has been requested.
Information has been received from a registered nurse concerning a female patient who already received two doses of MMR II at the correct time. On an unknown date, the patient was found to have zero titer upon a routine lab test. On approximately 18-JUN-2010 ("4 weeks ago"), the now 18 year old patient was vaccinated with the third dose of MMR II by the nurse. The patient's college was requiring her to receive another dose, for reasons unknown to nurse. It reported that there was no other adverse event. At the time of reporting, the outcome was unknown. It was unknown if the patient sought medical attention. Additional information has been requested.
Swollen arm; 102 degree fever; Chills 3 hours after the shot; This spontaneous case was reported by an other health care professional and describes the occurrence of PERIPHERAL SWELLING (Swollen arm), PYREXIA (102 degree fever) and CHILLS (Chills 3 hours after the shot) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Swollen arm), PYREXIA (102 degree fever) and CHILLS (Chills 3 hours after the shot). At the time of the report, PERIPHERAL SWELLING (Swollen arm), PYREXIA (102 degree fever) and CHILLS (Chills 3 hours after the shot) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102 degree (High) Pyrexia.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication list was not provided. Treatment information was not provided.
Immediately feeling hot and flushed. Face turned red and felt hot. After about 40 minutes and using the AC in the car, started feeling better. After getting home, approximately 1 hour after receiving the vaccine, having chills and a slight headache (not severe enough to take anything). About two hours later, arm started feeling slightly sore. At this point, chills had stopped and no more headache. The next day, no symptoms or discomfort, not even soreness in arm.
Patient reported a numb arm, as well as extreme soreness at injection site.  The patient experience a rash the next day on both arms, resembling chicken pox.  The patient reported the rash and symptoms two days later to the pharmacy and still had the rash at time of report.  He said that the rash was much more prevalent the day immediately following administration.  The patient also experienced mild flu like symptoms such as myalgia and also a dry mouth.
This spontaneous report was received from a pharmacist regarding a patient of unknown age and gender. Information on the concurrent condition, medical history and pertinent drug allergies of the patient were not reported. On 04-DEC-2015 at time- 14:36, the patient was vaccinated with improperly stored RECOMBIVAX HB lot # L025738 (expiry date, dose #, route, dose units and anatomical location were not specified). Concomitant medication was not reported. No adverse events were reported. The high temperature and low temperature at which the product was stored were 3.7 and 2.5 (units unspecified) respectively. There were no Product Quality Complaint (PQC) involved. This is one of several reports received from same reporter. Additional information has been requested.
Additional information was received on 11/10/03. The reported Hib-Titer lot number (M035N3) is not a valid lot number. A quality assurance investigation could not be performed due to incorrect product identification. Information was received from an attorney concerning a 14 month old male child on received his first dose of Acel-Imune vaccine on 4/22/97. Concomitant vaccines included the fourth dose of HibTiter vaccine and the fourth dose of Orimune vaccine as well as the first dose of MMR II. Relevant medical history was not provided. Indication for Acel-Imune vaccine was immunization. Product was administered on 4/22/97. Dose regimen was 1 dose 1 time per day (IM). Concomitant therapy included HibTiter vaccine. On 4/22/97, the reporter indicated that the child became very ill immediately following the vaccination. The patient developed fever, fatigue, diarrhea, irritability, and disorientation. After 4/22/97, the child developed severe gastrointestinal symptoms associated with bouts of diarrhea and constipation. The reporter stated that the child never used language again. In 1998, a diagnosis of autism was made. This event was considered medically important (OMIC). No additional information was available at the time of this report.
Information has been received from a new article via an journalist in a website referring to unspecified number of patients of unknown age and gender. Information about concurrent conditions, medical history and concomitant medication was not provided. On unknown dates the patients were vaccinated with doses of GARDASIL (dose, dose number, lot number, application and route were not reported). According to the research of Centers for Disease Control and Prevention, the researchers looked at problems reported to the Vaccine Adverse Events Reporting System in the 2.5 years since GARDASIL was licensed. There were 8.2 reports of fainting per 100,000 doses and 0.2 blood clots per 100,000 doses, the study shows. Other problems included nausea, headache, a skin reaction at the injection site, an allergic or hypersensitive reaction, skin rash, and autoimmune reactions such as Guillain-Barre syndrome, a potentially life-threatening condition in which the body's immune system attacks part of the nervous system. The outcome of event was not reported. The causality was unknown. Upon internal review, Guillain-Barre syndrome was considered to be medically significant event. This is one of several reports received from the same source. Additional information is not expected since there was no contact details provided.
Numbness in hand urgent care visit, steroids prescribed, numbness still persists. 3 days of steroids left
Increased temperature 108 after received flu vaccine.  Mom gave Motrin, pedialyte and advised cool compresses to cool child down.  Temperature decreased to 101 after a few hours.  Child was taken to MD that same night.  MD told parent that increased temperature was due to flu vaccine. Child developed blister in mouth also.  MD instructed parents to continue with Motrin, pedialyte, cool compresses and to give prescription of Amoxicillin ever 6 hours for 7 days.  child ok now.
PT CALLED AND SAID HER INJECTION SITE IS SORE AND HAS REDNESS THAT EXTENDS OUT FOR 4 INCHES.  I ASKED PATIENT TO PUT HYDROCORTISONE 1 % ON SITE AND REPORT TO DOCTOR IF REDNESS AREA INCREASES.
3 months after Pfizer dose 3, I had a reaction I began having Atrial Fib (on and off).
At approximately 9:20 am the patient received her COVID 19 Pfizer Bivalent booster vaccine and Influenza vaccine in opposite arms.  She was asked to wait in observation for 30 minutes due to her history of severe allergic reaction to sulfa, She agreed.  At approximately 9:40 am, the patient reported to staff that her throat was feeling scratchy.  He had her sit in observation and alerted the nurses.  A nurse assessed her while checking her pulse and as she did so the patient then complained of feeling lightheaded.  She was given a bottle of water and encouraged to put her head down between her legs.  As staff assessed patient through conversation, she drank her water without difficulty and was able to talk clearly and easily without difficulty.  She talked about her allergic reactions and said this reaction felt like other allergic reactions she has experienced and stated she normally would take a 25mg tablet of Benadryl and would improve.  She had it in the car but not with her.   Generic Benadryl (diphenhydramine) in liquid form was available in the emergency bag.  When offered, She immediately said yes and took 10ml (equivalent to 25mg tablet).   We continued to talk with her and she said her head was starting to feel more normal and by 10:10am she felt her throat felt normal again.   patient was educated to call emergency assistance number if symptoms return or get worse.  She was asked if she wanted assistance to get home, she reported living fairly close.  She declined assistance.
(L) arm pain Following Admin -> restless night with poor sleep due to pain. Also had HA and nausea. The morning if 8/7/19 pt. awakened with pain, fever, chills & subsequently fainted while walking in her home. Taken to ED.
RIGHT LEG CRAMPING; TINGLING OF ARM AND HAND; NUMBNESS OF ARM AND HAND; PAIN IN ARM; FATIGUE; GENERALISED ACHING; SPIDER VEINS HURTING; This spontaneous report received from a patient concerned a 41 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included spider veins. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced spider veins hurting. On 12-APR-2021, the subject experienced generalised aching. On 12-APR-2021, the subject experienced pain in arm. On 12-APR-2021, the subject experienced fatigue. On 13-APR-2021, the subject experienced right leg cramping. On 13-APR-2021, the subject experienced tingling of arm and hand. On 13-APR-2021, the subject experienced numbness of arm and hand. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the generalized aching, fatigue, pain in arm, right leg cramping, tingling of arm and hand, numbness of arm and hand and spider veins hurting was not reported. This report was non-serious.
Recombinant Zoster Vaccine, RZV. Pain and reduced range of motion in upper right arm. For the past 4 weeks the pain has increased and I am unable to move my arm to some positions. It is inhibiting my ability to perform everyday tasks. It is painful while sleeping. I hope this is not permanent.
Report left arm stiffness and pain one month post injection. Treatment: Aleve; Outcome: Mild improvement does not interfere with ADLs.
This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching really bad), SWOLLEN TONGUE (her tongue was swollen), GLOSSODYNIA (sore on left side of tongue) and RASH (rash under arms and around where the elastic on the bra goes around the back) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced PRURITUS (itching really bad) and RASH (rash under arms and around where the elastic on the bra goes around the back). On 31-Mar-2021, the patient experienced SWOLLEN TONGUE (her tongue was swollen). On 01-Apr-2021, the patient experienced GLOSSODYNIA (sore on left side of tongue). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PRURITUS (itching really bad), SWOLLEN TONGUE (her tongue was swollen), GLOSSODYNIA (sore on left side of tongue) and RASH (rash under arms and around where the elastic on the bra goes around the back) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were reported.
Rash on abdomen compatible w Herpes Zoster- confirmed by patient's rheumatologist.
This is in follow-up to report(s) previously submitted on 12/23/2008. Initial and follow-up information have been received from a registered pharmacist and an 84 year old retired female with gastric side effects to salicylate and NSAIDS, osteoporosis, diagnosed with unspecified cancer in 1985 and received "flu shot" on 14-OCT-2008 and a history of a history of scarlet fever when she was 11 years old, pneumonia as a child, who on 15-NOV-2008 was vaccinated with the first dose of ZOSTAVAX (Merck) SC 0.65 ml (lot # not reported) at 11:00. Concomitant therapy included PROTONIX, FORTICAL, enteric coated aspirin and loperamide HCl. On 21-NOV-2008 (also reported as "approximately 1-2 weeks after vaccination) the patient started to experience being "ice cold" and chilly that lasted for 2 days. The patient recovered from cold and chilly on 23-NOV-2008. The patient sought medical attention and spoke to the registered pharmacist. Follow-up information was received. The patient's feeling of being extremely cold lasted for approximately 2 days. No other symptoms were noted. The patient recovered on 23-NOV-2008. Additional information is not expected.
Patient walked into the grocery store where the clinic is located. He was shopping for produce and started to feel very dizzy and like he would pass out.  He came back to the clinic. Lay him down, put legs up. He started to feel better.  BP measured 100/64.  He sat up and drank some water. Ate a lollipop.  After another 15 minutes felt 90% better and wished to leave, son to drive him home.
Patient received Bivalent 5-11 via left arm, instead of Bivalent 12+; no symptoms or reaction.
8/20/21 PMH of polio, non-ambulatory, presents with progressive pain, weakness and stiffness.
Within 4 days, broke out with fever blister on my bottom lip of my mouth. treated with Abreva. Also started getting itchy skin, first on ankles, and also odd pains at different areas. Quick sharp, come and go. Around December 18th, 2022, i got small bumps blisters on my left rib cage, more red pimple like things that started to itch. They have since spread to my right rib cage and my armpit areas, and my lower abdomen. Not sure if it is the shingles. It is taking long time to spread and still spreading. I went to clinic today 1/3/2023 to have blood and urine taken for kidney test. Worried my kidneys could fail.  I am also having joint pains, or muscles pains.
Patient DOB:  10/27/1987   Date of Admission: 7/5/2022   Date of Discharge: 7/8/2022   Diagnosis: Vaginal Delivery   Hospital Course    OB History Gravida Para Term Preterm AB Living 6 5 5   1 5 SAB IAB Ectopic Multiple Live Births    1     0 1      # Outcome Date GA Lbr Len/2nd Weight Sex Delivery Anes PTL Lv 6 Term 07/06/22 39w3d   3.856 kg (8 lb 8 oz) F Vag-Spont None   LIV 5 Term 12/26/13     3.289 kg (7 lb 4 oz) M Vag-Spont       4 Term 07/12/12     2.778 kg (6 lb 2 oz) F Vag-Spont   N      Birth Comments: cleft palate 3 Term 03/30/10     3.402 kg (7 lb 8 oz) M Vag-Spont       2 Term 08/04/06     3.515 kg (7 lb 12 oz) M VBAC   N   1 SAB                         The patient  underwent a Vaginal delivery during this hospitalization.  She is now 2 days postpartum.  She has not had complications since the delivery.  She has not been febrile.  She did not have a surgical sterilization at the time of her delivery.     At the time of discharge, the patient was afebrile and has been tolerating a regular diet.  She has been ambulating and voiding without difficulty.  Denies symptoms of orthostasis.    Plan   She has been given discharge instructions which include the following: No straining, No lifting over 15 pounds, No sex, No tampons, No douche and No tub baths.  Follow up for a postpartum exam in 6 weeks.  Call for any signs of fever, foul discharge, increased bleeding, wound redness or draining, or signs of postpartum depression.   Discharge Medications   Motrin 800 mg one every 8 hours #30     Signed: 7/8/2022 8:00 AM
Information has been received from a consumer concerning her 6 year old son with no allergies and a history of pneumonia at 3 year old and intussusception at unspecified time who in 2007 was vaccinated with a dose of MUMPSVAX II (route and LOT# not reported), a dose of ATTENUVAX and a dose of MERUVAX. There was no concomitant medication. He did not receive any further doses. An unspecified blood work was performed recently (in 2009) that showed immunity in measles and rubella but titers for mumps was low. The patient sought unspecified medical attention and his outcome was unknown at this time of the report. No further information is available.
FLUZONE HIGH DOSE WAS GIVEN TO PATIENT THAT IS UNDER THE AGE (65+) INDICATED FOR VACCINE